Lombard Medical Technologies (LSE:LMT) Interest Expense : £0.00 Mil (TTM As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Lombard Medical Technologies's interest expense for the six months ended in Dec. 2012 was £ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2012 was £0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Lombard Medical Technologies's Operating Income for the six months ended in Dec. 2012 was £ -8.24 Mil. Lombard Medical Technologies's Interest Expense for the six months ended in Dec. 2012 was £ 0.00 Mil. Lombard Medical Technologies has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Lombard Medical Technologies Interest Expense Historical Data

The historical data trend for Lombard Medical Technologies's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Interest Expense Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Interest Expense

Get a 7-Day Free Trial

-0.06

-0.04

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
Interest Expense	Get a 7-Day Free Trial					-0.06	-0.04	-	-	-

Lombard Medical Technologies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Dec. 2012 was £0.00 Mil.

Lombard Medical Technologies (LSE:LMT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lombard Medical Technologies's Interest Expense for the six months ended in Dec. 2012 was £0.00 Mil. Its Operating Income for the six months ended in Dec. 2012 was £-8.24 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2012 was £0.00 Mil.

Lombard Medical Technologies's Interest Coverage for the quarter that ended in Dec. 2012 is calculated as

Lombard Medical Technologies had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies interest coverage is at least 5. Lombard Medical Technologies PLC has enough cash to cover all of its debt. Its financial situation is stable.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.